ErytechSQZ collaboration to realize immunemodulating potential

Erytech-SQZ collaboration to ‘realize immune-modulating potential’

Erytech entered an agreement with SQZ to advance RBC-based therapeutics for immune modulation using the latterâs platform.

Original Article: Erytech-SQZ collaboration to ‘realize immune-modulating potential’

More From BioPortfolio on "Erytech-SQZ collaboration to ‘realize immune-modulating potential’"